Eosinophilia granuloma

Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation

Post author:julia.rsoholland@gmail.com
Post published:22/07/2019
Post category:Eosinophilia granuloma
Post comments:0 Comments

The present review aims to elucidate the emerging role played by cannabinomimetic compounds in the control of mast cell activation. Mast cells are immune competent cells strategically localised at the…

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study

Post author:julia.rsoholland@gmail.com
Post published:22/07/2019
Post category:Eosinophilia granuloma
Post comments:0 Comments

Fifteen cats with eosinophilic granuloma or eosinophilic plaque were given PLR 120 at the dosage of 10 mg kg−1 twice daily for one month. PLR‐120 down‐modulates mast cell degranulation via a…

Cannabinoid system in the skin – a possible target for future therapies in dermatology

Post author:julia.rsoholland@gmail.com
Post published:22/07/2019
Post category:Eosinophilia granuloma
Post comments:0 Comments

Abstract: Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is…

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals

Post author:julia.rsoholland@gmail.com
Post published:22/07/2019
Post category:Eosinophilia granuloma
Post comments:0 Comments

Endocannabinoids have analgesic/anti-inflammatory properties. The biology of endocannabinoids, their receptors, signalling mechanisms and role in the regulation of physiological processes have been extensively reviewed. This review focuses on the role…